CONSORT Statement for randomized Trials of nonpharmacologic treatments: A 2017 update and a CONSORT extension for nonpharmacologic Trial Abstracts

Annals of Internal Medicine

Volumn 167, Issue 1, 2017, Pages 40-47

  Barbour, Virginia ^a   Bhui, Kamaldeep ^b   Chescheir, Nancy ^c   Clavien, Pierre Alain ^d   Diener, Markus K ^e   Glasziou, Paul ^f   Golub, Robert M ^g   Grimshaw, Jeremy M ^h   Groves, Trish ⁱ   Hopewell, Sally ^j   Lamb, Sarah E ^j   McCulloch, Peter ^j   Mulrow, Cynthia ^k   Riddle, Daniel ^l   Ross, Joseph S ^m   Schnurr, Paula P ⁿ   Schriger, David ^o   Shamseer, Larissa ^h   Torgerson, David ^p   Boutron, Isabelle ^q   Altman, Douglas G ^j   Moher, David ^h   Schulz, Kenneth F ^r   Ravaud, Philippe ^q   more..

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f BOND UNIVERSITY   (Australia)

^g JAMA   (India)

^h OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

ⁱ BMJ   (United Kingdom)

^j UNIVERSITY OF OXFORD   (United Kingdom)

^k UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^l VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^m YALE UNIVERSITY   (United States)

ⁿ DARTMOUTH MEDICAL SCHOOL   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p UNIVERSITY OF YORK   (United Kingdom)

^q HÔTEL DIEU   (France)

^r FAMILY HEALTH INTERNATIONAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONSENSUS DEVELOPMENT; HUMAN; MEDICAL LITERATURE; METHODOLOGY; PEER REVIEW; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL ANALYSIS; PUBLISHING; QUALITY CONTROL; STANDARDS; THERAPY;

PUBLISHING; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; THERAPEUTICS;

EID: 85021845232     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M17-0046     Document Type: Article

References (43)

1. Glasziou P, Altman DG, Bossuyt P, Boutron I, Clarke M, Julious S, et al. Reducing waste from incomplete or unusable reports of biomedical research. Lancet. 2014;383:267-76. [PMID: 24411647] doi: 10.1016/S0140-6736 (13) 62228-X
2. Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet. 2009;374:86-9. [PMID: 19525005] doi:10.1016/S0140-6736 (09) 60329-9
3. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996;276:637-9. [PMID: 8773637]
4. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, et al; CONSORT Group (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134:663-94. [PMID: 11304107] doi:10.7326/0003-4819-134-8-200104170-00012
5. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869. [PMID: 20332511] doi:10.1136/bmj.c869
6. Ceelen WP. Clinical research in surgery: threats and opportunities. Eur Surg Res. 2014;53:95-107. [PMID: 25247239] doi:10.1159/000367606
7. Evrard S, McKelvie-Sebileau P, van de Velde C, Nordlinger B, Poston G. What can we learn from oncology surgical trials? Nat Rev Clin Oncol. 2016;13:55-62. [PMID: 26483296] doi:10.1038/nrclinonc.2015.176
8. Boutron I, Tubach F, Giraudeau B, Ravaud P. Methodological differences in clinical trials evaluating nonpharmacological and pharmacological treatments of hip and knee osteoarthritis. JAMA. 2003;290:1062-70. [PMID: 12941679]
9. Boutron I, Guittet L, Estellat C, Moher D, Hróbjartsson A, Ravaud P. Reporting methods of blinding in randomized trials assessing nonpharmacological treatments. PLoS Med. 2007;4:e61. [PMID: 17311468]
10. Boutron I, Tubach F, Giraudeau B, Ravaud P. Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials. J Clin Epidemiol. 2004;57:543-50. [PMID: 15246122]
11. Pibouleau L, Boutron I, Reeves BC, Nizard R, Ravaud P. Applicability and generalisability of published results of randomised controlled trials and non-randomised studies evaluating four orthopaedic procedures: methodological systematic review. BMJ. 2009;339:b4538. [PMID: 19920015] doi:10.1136/bmj.b4538
12. Ergina PL, Cook JA, Blazeby JM, Boutron I, Clavien PA, Reeves BC, et al; Balliol Collaboration. Challenges in evaluating surgical innovation. Lancet. 2009;374:1097-104. [PMID: 19782875] doi:10.1016/S0140-6736 (09) 61086-2
13. Cook JA. The challenges faced in the design, conduct and analysis of surgical randomised controlled trials. Trials. 2009;10:9. [PMID: 19200379] doi:10.1186/1745-6215-10-9
14. McCulloch P, Altman DG, Campbell WB, Flum DR, Glasziou P, Marshall JC, et al; Balliol Collaboration. No surgical innovation without evaluation: the IDEAL recommendations. Lancet. 2009;374:1105-12. [PMID: 19782876] doi:10.1016/S0140-6736 (09) 61116-8
15. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P; CONSORT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008;148:295-309. [PMID: 18283207] doi:10.7326/0003-4819-148-4-200802190-00008
16. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P; CONSORT Group. Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments. Ann Intern Med. 2008;148:W60-6. [PMID: 18283201] doi:10.7326/0003-4819-148-4-200802190-00008-w1
17. Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med. 2010;7:e1000251. [PMID: 20352064] doi:10.1371/journal.pmed.1000251
18. Hopewell S, Clarke M, Moher D, Wager E, Middleton P, Altman DG, et al; CONSORT Group. CONSORT for reporting randomised trials in journal and conference abstracts. Lancet. 2008;371:281-3. [PMID: 18221781] doi:10.1016/S0140-6736 (07) 61835-2
19. Hopewell S, Clarke M, Moher D, Wager E, Middleton P, Altman DG, et al; CONSORT Group. CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med. 2008;5:e20. [PMID: 18215107] doi:10.1371/journal.pmed.0050020
20. Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, et al. Process evaluation of complex interventions: Medical Research Council guidance. BMJ. 2015;350:h1258. [PMID: 25791983] doi:10.1136/bmj.h1258
21. Blencowe NS, Blazeby JM, Donovan JL, Mills N. Novel ways to explore surgical interventions in randomised controlled trials: applying case study methodology in the operating theatre. Trials. 2015;16:589. [PMID: 26710760] doi:10.1186/s13063-015-1127-x
22. Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: Template for Intervention Description and Replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687. [PMID: 24609605] doi:10.1136/bmj.g1687
23. Halm EA, Lee C, Chassin MR. Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann Intern Med. 2002;137:511-20. [PMID: 12230353]
24. Cook JA, Bruckner T, MacLennan GS, Seiler CM. Clustering in surgical trials-database of intracluster correlations. Trials. 2012;13:2. [PMID: 22217216] doi:10.1186/1745-6215-13-2
25. Roberts C, Roberts SA. Design and analysis of clinical trials with clustering effects due to treatment. Clin Trials. 2005;2:152-62. [PMID: 16279137]
26. Kahan BC, Morris TP. Assessing potential sources of clustering in individually randomised trials. BMC Med Res Methodol. 2013;13:58. [PMID: 23590245] doi:10.1186/1471-2288-13-58
27. Lee KJ, Thompson SG. Clustering by health professional in individually randomised trials. BMJ. 2005;330:142-4. [PMID: 15649931]
28. Roberts C, Walwyn R. Design and analysis of nonpharmacological treatment trials with multiple therapists per patient. Stat Med. 2013;32:81-98. [PMID: 22865729] doi:10.1002/sim.5521
29. Roberts C. The implications of variation in outcome between health professionals for the design and analysis of randomized controlled trials. Stat Med. 1999;18:2605-15. [PMID: 10495459]
30. Lee KJ, Thompson SG. The use of random effects models to allow for clustering in individually randomized trials. Clin Trials. 2005;2:163-73. [PMID: 16279138]
31. Wartolowska K, Judge A, Hopewell S, Collins GS, Dean BJ, Rombach I, et al. Use of placebo controls in the evaluation of surgery: systematic review. BMJ. 2014;348:g3253. [PMID: 24850821] doi:10.1136/bmj.g3253
32. Torgerson D. Designing Randomised Trials in Health, Education and the Social Sciences. An Introduction. London: Palgrave Macmillan UK; 2008.
33. Thornton JG, Hornbuckle J, Vail A, Spiegelhalter DJ, Levene M; GRIT study group. Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial. Lancet. 2004;364:513-20. [PMID: 15302194]
34. Burton AK, Tillotson KM, Cleary J. Single-blind randomised controlled trial of chemonucleolysis and manipulation in the treatment of symptomatic lumbar disc herniation. Eur Spine J. 2000;9:202-7. [PMID: 10905437]
35. Hoffmann TC, Erueti C, Glasziou PP. Poor description of nonpharmacological interventions: analysis of consecutive sample of randomised trials. BMJ. 2013;347:f3755. [PMID: 24021722] doi:10.1136/bmj.f3755
36. Nagendran M, Harding D, Teo W, Camm C, Maruthappu M, McCulloch P, et al. Poor adherence of randomised trials in surgery to CONSORT guidelines for non-pharmacological treatments (NPT): a cross-sectional study. BMJ Open. 2013;3:e003898. [PMID: 24353256] doi:10.1136/bmjopen-2013-003898
37. Baker M. 1, 500 scientists lift the lid on reproducibility. Nature. 2016;533:452-4. [PMID: 27225100] doi:10.1038/533452a
38. Dworkin JD, McKeown A, Farrar JT, Gilron I, Hunsinger M, Kerns RD, et al. Deficiencies in reporting of statistical methodology in recent randomized trials of nonpharmacologic pain treatments: ACTTION systematic review. J Clin Epidemiol. 2016;72:56-65. [PMID: 26597977] doi:10.1016/j.jclinepi.2015.10.019
39. Yu J, Li X, Li Y, Sun X. Quality of reporting in surgical randomized clinical trials. Br J Surg. 2017;104:296-303. [PMID: 27918069] doi:10.1002/bjs.10331
40. McCleary N, Duncan EM, Stewart F, Francis JJ. Active ingredients are reported more often for pharmacologic than nonpharmacologic interventions: an illustrative review of reporting practices in titles and abstracts. Trials. 2013;14:146. [PMID: 23688143] doi:10.1186/1745-6215-14-146
41. Chan L, Heinemann AW, Roberts J. Elevating the quality of disability and rehabilitation research: mandatory use of the reporting guidelines [Editorial]. Arch Phys Med Rehabil. 2014;95:415-7. [PMID: 24559651] doi:10.1016/j.apmr.2013.12.010
42. Barnes C, Boutron I, Giraudeau B, Porcher R, Altman DG, Ravaud P. Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial. BMC Med. 2015;13:221. [PMID: 26370288] doi:10.1186/s12916-015-0460-y
43. Moher D, Schulz KF, Simera I, Altman DG. Guidance for developers of health research reporting guidelines. PLoS Med. 2010;7:e1000217. [PMID: 20169112] doi:10.1371/journal.pmed.1000217